Hcp1-loaded staphylococcal membrane vesicle vaccine protects against acute melioidosis
暂无分享,去创建一个
Gang Li | Ming Li | Yifan Rao | X. Rao | Keting Zhu | Renjie Zhou | Jia Li | Mingxia Zheng | Xiaohui Peng
[1] Jennifer L. Dankmeyer,et al. Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice , 2022, Frontiers in Microbiology.
[2] Xiao Zhao,et al. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery , 2022, Nature Protocols.
[3] R. Vandenbroucke,et al. The tremendous biomedical potential of bacterial extracellular vesicles. , 2022, Trends in biotechnology.
[4] Yifan Rao,et al. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus , 2021, Journal of advanced research.
[5] Yifan Rao,et al. Engineered Remolding and Application of Bacterial Membrane Vesicles , 2021, Frontiers in Microbiology.
[6] J. Lötvall,et al. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy , 2021, Journal of extracellular vesicles.
[7] A. Torres,et al. Antigen-specific antibody and polyfunctional T cells generated by respiratory immunization with protective BurkholderiaΔtonBΔhcp1 live attenuated vaccines , 2021, npj Vaccines.
[8] M. Valvano,et al. Current Advances in Burkholderia Vaccines Development , 2020, Cells.
[9] C. Bayliss,et al. Broad vaccine protection against Neisseria meningitidis using factor H binding protein. , 2020, Vaccine.
[10] T. Nagakubo,et al. Cracking Open Bacterial Membrane Vesicles , 2020, Frontiers in Microbiology.
[11] Ammar Aziz,et al. Comparative genomics confirms a rare melioidosis human-to-human transmission event and reveals incorrect phylogenomic reconstruction due to polyclonality , 2019, bioRxiv.
[12] E. Bertherat,et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. , 2019, The Lancet. Infectious diseases.
[13] A. Torres,et al. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis , 2019, PLoS neglected tropical diseases.
[14] A. Torres,et al. Novel multi‐component vaccine approaches for Burkholderia pseudomallei , 2019, Clinical and experimental immunology.
[15] R. Cabeza,et al. Present and Future , 2008 .
[16] A. Torres,et al. Burkholderia pseudomallei ΔtonB Δhcp1 Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection , 2019, mSphere.
[17] B. He,et al. The autotransporter protein BatA is a protective antigen against lethal aerosol infection with Burkholderia mallei and Burkholderia pseudomallei , 2018, Vaccine: X.
[18] P. Keim,et al. Caprine humoral response to Burkholderia pseudomallei antigens during acute melioidosis from aerosol exposure , 2018, bioRxiv.
[19] I. Steinmetz,et al. Melioidosis in Vietnam: Recently Improved Recognition but still an Uncertain Disease Burden after Almost a Century of Reporting , 2018, Tropical medicine and infectious disease.
[20] S. Iamsirithaworn,et al. Melioidosis in Thailand: Present and Future , 2018, Tropical medicine and infectious disease.
[21] D. Limmathurotsakul,et al. Global Burden and Challenges of Melioidosis , 2018, Tropical medicine and infectious disease.
[22] X. Rao,et al. Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections. , 2018, Nano letters.
[23] A. Torres,et al. Melioidosis , 1975, Nature Reviews Disease Primers.
[24] Laura A. Muruato,et al. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis , 2017, Infection and Immunity.
[25] W. Wiersinga,et al. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application , 2017, Virulence.
[26] R. Berisio,et al. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. , 2016, Vaccine.
[27] B. Wren,et al. Intracellular replication of the well-armed pathogen Burkholderia pseudomallei. , 2016, Current opinion in microbiology.
[28] S. Hay,et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis , 2016, Nature Microbiology.
[29] C. Peano,et al. Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063. , 2015, Acta crystallographica. Section D, Biological crystallography.
[30] D. Altmann,et al. Consensus on the Development of Vaccines against Naturally Acquired Melioidosis , 2015, Emerging infectious diseases.
[31] K. Vowles,et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis , 2015, Pain.
[32] Laura A. Muruato,et al. Recent Advances in Burkholderia mallei and B. pseudomallei Research , 2015, Current Tropical Medicine Reports.
[33] M. Raida,et al. Extended Loop Region of Hcp1 is Critical for the Assembly and Function of Type VI Secretion System in Burkholderia pseudomallei , 2015, Scientific Reports.
[34] S. Nathan,et al. Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker. , 2015, Microbial pathogenesis.
[35] J. Lötvall,et al. Bacterial protoplast-derived nanovesicles as vaccine delivery system against bacterial infection. , 2015, Nano letters.
[36] Robert Anderson,et al. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge. , 2014, Vaccine.
[37] Nancy L Price,et al. Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery , 2014, Front. Microbiol..
[38] A. Torres,et al. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Protection against Lethal Sepsis , 2014, Clinical and Vaccine Immunology.
[39] R. M. Wooten,et al. Development of novel O-polysaccharide based glycoconjugates for immunization against glanders , 2012, Front. Cell. Inf. Microbio..
[40] Y. Tong,et al. First Genome Sequence of a Burkholderia pseudomallei Isolate in China, Strain BPC006, Obtained from a Melioidosis Patient in Hainan , 2012, Journal of bacteriology.
[41] K. Brown,et al. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. , 2011, Vaccine.
[42] I. Feavers,et al. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines , 2011, Expert review of vaccines.
[43] D. DeShazer,et al. The Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei , 2011, Infection and Immunity.
[44] K. Wan,et al. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. , 2010, Vaccine.
[45] K. Brown,et al. Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. , 2010, Procedia in vaccinology.
[46] R. Titball,et al. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. , 2009, Vaccine.
[47] J. Köhler,et al. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[48] R. Titball. Vaccines against intracellular bacterial pathogens. , 2008, Drug discovery today.
[49] K. Brown,et al. Identification of a LolC Homologue in Burkholderia pseudomallei, a Novel Protective Antigen for Melioidosis , 2007, Infection and Immunity.
[50] Yin Liu,et al. CpG-Modified Plasmid DNA Encoding Flagellin Improves Immunogenicity and Provides Protection against Burkholderia pseudomallei Infection in BALB/c Mice , 2006, Infection and Immunity.
[51] G. Dougan,et al. A Mutant of Burkholderia pseudomallei, Auxotrophic in the Branched Chain Amino Acid Biosynthetic Pathway, Is Attenuated and Protective in a Murine Model of Melioidosis , 2002, Infection and Immunity.
[52] Y. Suputtamongkol,et al. Risk factors for melioidosis and bacteremic melioidosis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.